Picture of Thermogenesis Holdings logo

THMO — Thermogenesis Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro Cap

Brief: Thermogenesis Holdings Announces That ImmuneCyte Joint Venture Receives $3 Mln Equity Investment

Jan 3 (Reuters) - Thermogenesis Holdings Inc  THMO.O :
    * THERMOGENESIS HOLDINGS ANNOUNCES THAT IMMUNECYTE JOINT
VENTURE
RECEIVES $3.0 MILLION EQUITY INVESTMENT
    * THERMOGENESIS - INVESTOR RECEIVED 600,000 SHARES OF CLASS
A
STOCK AT $5.00/SHARE, REPRESENTING A 5.66% OWNERSHIP IN JV
    * THERMOGENESIS - AFTER INVESTMENT, IMMUNECYTE IS OWNED
75.47% BY
HEALTHBANKS BIOTECH (USA), 18.87% BY CO, 5.66% BY THE PRIVATE
INSTITUTION
    * THERMOGENESIS HOLDINGS - BECAUSE OF EQUITY INVESTMENT IN
IMMUNECYTE, CO' EQUITY IN JV IS NO LONGER SUBJECT TO
ANTI-DILUTION PROVISION

Source text for Eikon:  ID:nPn8pYhRja 
Further company coverage:  THMO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Thermogenesis Holdings

See all news